NYSE:HNGE • US4333131039
The current stock price of HNGE is 41.02 USD. In the past month the price decreased by -3.49%.
ChartMill assigns a fundamental rating of 3 / 10 to HNGE. HNGE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months HNGE reported a non-GAAP Earnings per Share(EPS) of -13.87. The EPS decreased by -4978.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.05% | ||
| ROE | -167.34% | ||
| Debt/Equity | 0 |
23 analysts have analysed HNGE and the average price target is 64.32 USD. This implies a price increase of 56.81% is expected in the next year compared to the current price of 41.02.
For the next year, analysts expect an EPS growth of 5.3% and a revenue growth 26.66% for HNGE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.51 | 94.166B | ||
| CI | THE CIGNA GROUP | 9.1 | 74.032B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.49 | 24.337B | ||
| LH | LABCORP HOLDINGS INC | 15.79 | 23.803B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.81 | 23.309B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.291B | ||
| DVA | DAVITA INC | 11.04 | 10.345B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.84 | 7.268B | ||
| CHE | CHEMED CORP | 17.92 | 6.631B | ||
| OPCH | OPTION CARE HEALTH INC | 17.42 | 5.367B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
HINGE HEALTH INC-A
455 Market Street, Suite 700
San Francisco CALIFORNIA US
Employees: 1514
Phone: 14156898429
Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
The current stock price of HNGE is 41.02 USD. The price increased by 2.27% in the last trading session.
HNGE does not pay a dividend.
HNGE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
HNGE stock is listed on the New York Stock Exchange exchange.
The Revenue of HINGE HEALTH INC-A (HNGE) is expected to grow by 26.66% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
You can find the ownership structure of HINGE HEALTH INC-A (HNGE) on the Ownership tab.